Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


2 AIDS Res Hum Retroviruses
1 BMC Cancer
3 Clin Infect Dis
1 Drugs
3 HIV Med
12 J Acquir Immune Defic Syndr
6 J Infect Dis
3 J Virol
2 Lancet HIV
3 Lancet Infect Dis
4 Pediatr Infect Dis J
1 PLoS Med
9 PLoS One


  1. DURAND-ZALESKI I, Mutuon P, Charreau I, Tremblay C, et al
    Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.
    AIDS. 2018;32:95-102.
    >> Share

  2. BERNARDES C, Russo P, Carvalho D, Saiote J, et al
    Primary HIV infection in a Crohn's disease patient receiving infliximab maintenance therapy.
    AIDS. 2018;32:130-131.
    >> Share

  3. YOSHIMURA Y, Miyata N, Komatsu H, Tachikawa N, et al
    Remarkable plasma HIV RNA decrease by ombitasvir/paritaprevir/ritonavir in an HIV-HCV coinfection case.
    AIDS. 2018;32:128-129.
    >> Share

  4. CATTANEO D, Rizzardini G, Gervasoni C
    Psychoactive drugs and HIV: are we sure to treat our patients adequately?
    AIDS. 2018;32:127-128.
    >> Share

    AIDS Res Hum Retroviruses

  5. NOVITSKY V, Prague M, Moyo S, Gaolathe T, et al
    High HIV-1 RNA among Newly Diagnosed People in Botswana.
    AIDS Res Hum Retroviruses. 2017 Dec 7. doi: 10.1089/AID.2017.0214.
    >> Share

  6. SYLLA LN, Evans D, Taylor J, Gilbertson AL, et al
    If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities - A Qualitative Focus Group Study.
    AIDS Res Hum Retroviruses. 2017 Dec 3. doi: 10.1089/AID.2017.0178.
    >> Share

    BMC Cancer

  7. BEKOLO CE, Soumah MM, Tiemtore OW, Diallo A, et al
    Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.
    BMC Cancer. 2017;17:806.
    >> Share

    Clin Infect Dis

  8. NOVELLI S, Lecuroux C, Avettand-Fenoel V, Seng R, et al
    Long-term therapeutic impact of the timing of ART in patients diagnosed with primary HIV-1 infection.
    Clin Infect Dis. 2017 Dec 2. pii: 4683678. doi: 10.1093/cid/cix1068.
    >> Share

  9. ROUET F, Nouhin J, Zheng DP, Roche B, et al
    Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015.
    Clin Infect Dis. 2017 Dec 4. pii: 4689456. doi: 10.1093/cid/cix1071.
    >> Share

  10. MA Y, Dou Z, Guo W, Mao Y, et al
    The Human Immunodeficiency Virus Care Continuum in China: 1985-2015.
    Clin Infect Dis. 2017 Dec 5. pii: 4693542. doi: 10.1093.
    >> Share


  11. PANSA P, Hsia Y, Bielicki J, Lutsar I, et al
    Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000-2016: A Systematic Review and Meta-Analysis.
    Drugs. 2017 Dec 7. pii: 10.1007/s40265-017-0850.
    >> Share

    HIV Med

  12. BASHIR T, Reddy K
    HbAHP-25 attenuates HIV-1 gp120 mediated inflammation and barrier dysfunction.
    HIV Med. 2017 Dec 6. doi: 10.1111/hiv.12569.
    >> Share

  13. MUKANYANGEZI MF, Sengpiel V, Manzi O, Tobin G, et al
    Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV-positive and HIV-negative women in Rwanda.
    HIV Med. 2017 Dec 6. doi: 10.1111/hiv.12564.
    >> Share

  14. ROSENTHAL E, Fougerou-Leurent C, Renault A, Carrieri MP, et al
    Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
    HIV Med. 2017 Dec 7. doi: 10.1111/hiv.12571.
    >> Share

    J Acquir Immune Defic Syndr

  15. WOOD D, Lancaster KE, Boily MC, Powers KA, et al
    Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently?
    J Acquir Immune Defic Syndr. 2017 Nov 28. doi: 10.1097/QAI.0000000000001603.
    >> Share

  16. LATAILLADE M, Zhou N, Joshi SR, Lee S, et al
    Viral Drug Resistance through 48 Weeks, in a Phase 2b, Randomized, Controlled Trial of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir.
    J Acquir Immune Defic Syndr. 2017 Nov 28. doi: 10.1097/QAI.0000000000001602.
    >> Share

  17. URICK B, Fong Y, Okiira C, Nabukeera-Barungi N, et al
    Rapid Serological Tests Ineffectively Screen for Hiv Exposure in Hiv-Positive Infants.
    J Acquir Immune Defic Syndr. 2017 Nov 28. doi: 10.1097/QAI.0000000000001609.
    >> Share

  18. ROHR JK, Ive P, Horsburgh CR, Berhanu R, et al
    Assessing the association between changing NRTIs when initiating second-line ART and treatment outcomes.
    J Acquir Immune Defic Syndr. 2017 Dec 4. doi: 10.1097/QAI.0000000000001611.
    >> Share

  19. LIPPMAN SA, Lane T, Rabede O, Gilmore H, et al
    High Acceptability and Increased HIV Testing Frequency Following Introduction of HIV Self-Testing and Network Distribution among South African MSM.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001601.
    >> Share

  20. LAFLEUR J, Bress AP, Esker S, Knippenberg K, et al
    Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001608.
    >> Share

  21. FLASH CA, Adegboyega OO, Yu X, Avalos C, et al
    Correlates of Linkage to HIV Pre-exposure Prophylaxis (PrEP) among HIV Testing Clients.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001605.
    >> Share

  22. FAMILIAR I, Collins SM, Sikorskii A, Ruisenor-Escudero H, et al
    Quality of caregiving is positively associated with neurodevelopment during the first year of life among HIV-exposed uninfected children in Uganda.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001599.
    >> Share

  23. CALKINS KL, Lesko CR, Chander G, Moore RD, et al
    Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen among Virally Suppressed Individuals.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001607.
    >> Share

  24. NEWCOMB ME, Moran K, Feinstein BA, Forscher E, et al
    Pre-Exposure Prophylaxis (PrEP) Use and Condomless Anal Sex: Evidence of Risk Compensation in a Cohort of Young Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001604.
    >> Share

  25. VAN EPPS P, Maier M, Lund B, Howren MB, et al
    "Medication Adherence in a Nationwide Cohort of Veterans Initiating Pre-Exposure Prophylaxis (PrEP) to Prevent HIV Infection".
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001598.
    >> Share

  26. GLESBY MJ, Hanna DB, Hoover DR, Shi Q, et al
    Abdominal Fat Depots and Subclinical Carotid Artery Atherosclerosis in Women with and without HIV Infection.
    J Acquir Immune Defic Syndr. 2017 Nov 27. doi: 10.1097/QAI.0000000000001606.
    >> Share

    J Infect Dis

  27. MAKVANDI-NEJAD S, Laurenson-Schafer H, Wang L, Wellington D, et al
    Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
    J Infect Dis. 2017 Nov 30. pii: 4676001. doi: 10.1093.
    >> Share

  28. RAIZES E, Hader S, Birx D
    Expansion of Viral Load Testing and the Potential Impact on HIV Drug Resistance.
    J Infect Dis. 2017;216.
    >> Share

  29. WALLIS CL, Godfrey C, Fitzgibbon JE, Mellors JW, et al
    Key Factors Influencing the Emergence of Human Immunodeficiency Virus Drug Resistance in Low- and Middle-Income Countries.
    J Infect Dis. 2017;216.
    >> Share

  30. STELLA-ASCARIZ N, Arribas JR, Paredes R, Li JZ, et al
    The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.
    J Infect Dis. 2017;216.
    >> Share

  31. PATEL P, Bush T, Kojic EM, Conley L, et al
    Prevalence, incidence, and clearance of anal high-risk human papillomavirus (HPV) infection among HIV-infected men in the SUN Study.
    J Infect Dis. 2017 Dec 4. pii: 4689803. doi: 10.1093.
    >> Share

  32. NYITRAY AG, Fujimoto K, Zhao J, Giuliano AR, et al
    Prevalence of and risk factors for anal HPV among a sample of predominantly black men who have sex with men in Houston, Texas.
    J Infect Dis. 2017 Dec 5. pii: 4690591. doi: 10.1093.
    >> Share

    J Virol

  33. PERNAS M, Tarancon-Diez L, Rodriguez-Gallego E, Gomez J, et al
    Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
    J Virol. 2017 Dec 6. pii: JVI.01805-17. doi: 10.1128/JVI.01805.
    >> Share

  34. KIRSCHMAN J, Qi M, Ding L, Hammonds J, et al
    HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment is Required for Particle Incorporation.
    J Virol. 2017 Dec 6. pii: JVI.01893-17. doi: 10.1128/JVI.01893.
    >> Share

  35. SATO K, Misawa N, Takeuchi JS, Kobayashi T, et al
    Experimental adaptive evolution of SIVcpz to pandemic HIV-1 using a humanized mouse model.
    J Virol. 2017 Dec 6. pii: JVI.01905-17. doi: 10.1128/JVI.01905.
    >> Share

    Lancet HIV

  36. LUNDGREN J, Phillips A
    Prevention of HIV transmission by antiretroviral therapy.
    Lancet HIV. 2017 Nov 30. pii: S2352-3018(17)30204.
    >> Share

  37. IWUJI CC, Orne-Gliemann J, Larmarange J, Balestre E, et al
    Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.
    Lancet HIV. 2017 Nov 30. pii: S2352-3018(17)30205.
    >> Share

    Lancet Infect Dis

  38. GUPTA RK, Gregson J, Parkin N, Haile-Selassie H, et al
    HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis.
    Lancet Infect Dis. 2017 Nov 30. pii: S1473-3099(17)30702.
    >> Share

  39. YERLY S, Calmy A
    Time to overcome pretreatment HIV drug resistance.
    Lancet Infect Dis. 2017 Nov 30. pii: S1473-3099(17)30709.
    >> Share

  40. DORMAN SE, Schumacher SG, Alland D, Nabeta P, et al
    Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
    Lancet Infect Dis. 2017 Nov 30. pii: S1473-3099(17)30691.
    >> Share

    Pediatr Infect Dis J

    Beyond Prevention of Vertical HIV Transmission - Improving Outcomes of HIV-Uninfected Infants Born to Mothers with HIV Infection.
    Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001854.
    >> Share

  42. PAUL R, Prasitsuebsai W, Jahanashad N, Puthanakit T, et al
    Structural Neuroimaging and Neuropsychologic Signatures of Vertically Acquired HIV.
    Pediatr Infect Dis J. 2017 Dec 1. doi: 10.1097/INF.0000000000001852.
    >> Share

  43. SEVINSKY H, Zaru L, Wang R, Xu X, et al
    Pharmacokinetics and Pharmacodynamics of Atazanavir in HIV-1-Infected Children Treated With Atazanavir Powder and Ritonavir: Combined Analysis of the PRINCE-1 and -2 Studies.
    Pediatr Infect Dis J. 2017 Dec 4. doi: 10.1097/INF.0000000000001855.
    >> Share

  44. COTTON MF, Liberty A, Torres-Escobar I, Gonzalez-Tome MI, et al
    Safety and Efficacy of Atazanavir Powder and Ritonavir in HIV-1-Infected Infants and Children Aged From 3 Months to <11 Years: the PRINCE-2 Study.
    Pediatr Infect Dis J. 2017 Dec 4. doi: 10.1097/INF.0000000000001856.
    >> Share

    PLoS Med

  45. DUBE K, Sylla L, Dee L, Taylor J, et al
    Research on HIV cure: Mapping the ethics landscape.
    PLoS Med. 2017;14:e1002470.
    >> Share

    PLoS One

  46. ALAMPALLI SV, Thomson MM, Sampathkumar R, Sivaraman K, et al
    Deep sequencing of near full-length HIV-1 genomes from plasma identifies circulating subtype C and infrequent occurrence of AC recombinant form in Southern India.
    PLoS One. 2017;12:e0188603.
    >> Share

  47. BRINKMANN C, Hoffmann M, Lubke A, Nehlmeier I, et al
    The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells.
    PLoS One. 2017;12:e0189073.
    >> Share

  48. DORTA-ESTREMERA S, Nehete PN, Yang G, He H, et al
    Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques.
    PLoS One. 2017;12:e0188807.
    >> Share

  49. FLICK RJ, Munthali A, Simon K, Hosseinipour M, et al
    Assessing infection control practices to protect health care workers and patients in Malawi from nosocomial transmission of Mycobacterium tuberculosis.
    PLoS One. 2017;12:e0189140.
    >> Share

  50. NOZZA S, Cozzi-Lepri A, Bai F, Rusconi S, et al
    Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort.
    PLoS One. 2017;12:e0189045.
    >> Share

  51. SHENDRE A, Wiener HW, Irvin MR, Aouizerat BE, et al
    Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).
    PLoS One. 2017;12:e0188725.
    >> Share

  52. PRUDDEN HJ, Hamilton M, Foss AM, Adams ND, et al
    Can mother-to-child transmission of HIV be eliminated without addressing the issue of stigma? Modeling the case for a setting in South Africa.
    PLoS One. 2017;12:e0189079.
    >> Share

  53. TSHIMANGA M, Makunike-Chikwinya B, Mangwiro T, Tapiwa Gundidza P, et al
    Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe.
    PLoS One. 2017;12:e0189146.
    >> Share

  54. CUZIN L, Pugliese P, Allavena C, Rey D, et al
    Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.
    PLoS One. 2017;12:e0187517.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016